Straumann Holding AG (STMN):企業の財務・戦略的SWOT分析

◆英語タイトル:Straumann Holding AG (STMN) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME726FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Straumann Holding AG (STMN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Straumann Holding AG (Straumann) is a provider of tooth replacement and orthodontic solutions. The company develops, manufactures and markets dental implants, instruments, digital equipment, CADCAM prosthetics, dental biomaterials, software and clear aligners for application in tooth replacement, restoration and prevention of tooth loss. It also provides training, support and other services to dental practitioners, clinics and laboratories. The company provides products and solutions for both conventional treatment and digital workflows including guided surgery and intra-oral scanning. The company distributes products, solutions and services directly and also through a network of partners in Europe, the Middle East and Africa, North America; Asia Pacific; and Latin America. Straumann is headquartered in Basel, Switzerland.

Straumann Holding AG Key Recent Developments

Dec 15,2020: Straumann Group appoints Rahma Samow to head fast-growing business with Dental Service Organizations
Dec 08,2020: Straumann announces leadership appointments to support growth and accelerate digital transformation
Aug 13,2020: Straumann Group sees sales pick up at end of tough first half, in which COVID-19 reduces revenue by 22% to CHF 605 million
Jul 09,2020: Straumann Group invests in DrSmile, a leading provider of clinician-led clear-aligner treatment solutions in Germany
Feb 18,2020: Straumann finishes 2019 with solid Q4, as full-year organic revenue climbs 17% and core EBIT margin expands to 27.1%

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Straumann Holding AG – Key Facts
Straumann Holding AG – Key Employees
Straumann Holding AG – Key Employee Biographies
Straumann Holding AG – Major Products and Services
Straumann Holding AG – History
Straumann Holding AG – Company Statement
Straumann Holding AG – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Affiliate
Section 2 – Company Analysis
Company Overview
Straumann Holding AG – Business Description
Business Segment: Implant Solutions
Overview
Performance
Business Segment: Other
Overview
Performance
Business Segment: Restorative Solutions
Overview
Performance
Geographical Segment: Asia Pacific
Target Markets
Performance
Geographical Segment: Europe, Middle East & Africa
Target Markets
Performance
Geographical Segment: LATAM
Target Markets
Geographical Segment: Latin America
Performance
Geographical Segment: North America
Target Markets
Performance
Straumann Holding AG – Corporate Strategy
Straumann Holding AG – SWOT Analysis
SWOT Analysis – Overview
Straumann Holding AG – Strengths
Straumann Holding AG – Weaknesses
Straumann Holding AG – Opportunities
Straumann Holding AG – Threats
Straumann Holding AG – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Straumann Holding AG, Medical Equipment, Deals By Year, 2015 to YTD 2021
Straumann Holding AG, Medical Equipment, Deals By Type, 2015 to YTD 2021
Straumann Holding AG, Recent Deals Summary
Section 5 – Company’s Recent Developments
Dec 15, 2020: Straumann Group appoints Rahma Samow to head fast-growing business with Dental Service Organizations
Dec 08, 2020: Straumann announces leadership appointments to support growth and accelerate digital transformation
Aug 13, 2020: Straumann Group sees sales pick up at end of tough first half, in which COVID-19 reduces revenue by 22% to CHF 605 million
Feb 18, 2020: Straumann finishes 2019 with solid Q4, as full-year organic revenue climbs 17% and core EBIT margin expands to 27.1%
Feb 03, 2020: Mark Johnson joins Straumann’s Executive Management as Head of Research, Development & Operations, succeeding Dr Gerhard Bauer, who is retiring after a distinguished career with the Group
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Straumann Holding AG, Key Facts
Straumann Holding AG, Key Employees
Straumann Holding AG, Key Employee Biographies
Straumann Holding AG, Major Products and Services
Straumann Holding AG, History
Straumann Holding AG, Subsidiaries
Straumann Holding AG, Affiliate
Straumann Holding AG, Key Competitors
Straumann Holding AG, Ratios based on current share price
Straumann Holding AG, Annual Ratios
Straumann Holding AG, Annual Ratios (Cont...1)
Straumann Holding AG, Annual Ratios (Cont...2)
Straumann Holding AG, Interim Ratios
Straumann Holding AG, Medical Equipment, Deals By Year, 2015 to YTD 2021
Straumann Holding AG, Medical Equipment, Deals By Type, 2015 to YTD 2021
Straumann Holding AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Straumann Holding AG (STMN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Probi AB (PROB):製薬・医療:M&Aディール及び事業提携情報
    Summary Probi AB (Probi) is a biotechnology company develops, produces and markets probiotics. The company offers licenses for its technology and sells finished products in bulk. It focuses on products for the improvement of gastrointestinal health and immune system. It distributes its products to l …
  • CITIC Securities Company Limited:企業の戦略・SWOT・財務分析
    CITIC Securities Company Limited - Strategy, SWOT and Corporate Finance Report Summary CITIC Securities Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Prima BioMed Ltd (PRR)-製薬・医療分野:企業M&A・提携分析
    Summary Prima BioMed Ltd (Prima BioMed) is a biotechnology company that develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. The company’s products are based on LAG-3 immune control mechanism which is active in the regulation of the T cell immune response. It deve …
  • Skyworth Digital Holdings Limited:企業の戦略・SWOT・財務分析
    Skyworth Digital Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Skyworth Digital Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Qatargas Operating Co Ltd:企業の戦略的SWOT分析
    Qatargas Operating Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Volpara Health Technologies Ltd (VHT):医療機器:M&Aディール及び事業提携情報
    Summary Volpara Health Technologies Ltd (Volpara Health) is a medical equipment company that develops and manufactures breast imaging analytics and analysis products that improve clinical decision-making and early detection of breast cancer. The company offers clinically-validated software products …
  • Stockmann plc (STCBV):企業の財務・戦略的SWOT分析
    Stockmann plc (STCBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Empresa Electricidad del Peru SA (ELECPBC1):企業の財務・戦略的SWOT分析
    Empresa Electricidad del Peru SA (ELECPBC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Biohit Oyj (BIOBV):医療機器:M&Aディール及び事業提携情報
    Summary Biohit Oyj (Biohit) is a biotechnology company that offers research and early diagnosis processing products. The company’s products comprise acetaldehyde binding products, diagnostic tests, dysbiosis test, microplate readers and washers, monoclonal antibodies, and pipettes. It targets therap …
  • Children’s Medical Center:企業の戦略的SWOT分析
    Children's Medical Center - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Mapletree Investments Pte Ltd:企業の戦略的SWOT分析
    Mapletree Investments Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Gartner Inc (IT):企業の財務・戦略的SWOT分析
    Gartner Inc (IT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Memorial Sloan Kettering Cancer Center:企業のM&A・事業提携・投資動向
    Memorial Sloan Kettering Cancer Center - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Memorial Sloan Kettering Cancer Center Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed repo …
  • Ottogi Corporation:企業の戦略・SWOT・財務情報
    Ottogi Corporation - Strategy, SWOT and Corporate Finance Report Summary Ottogi Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Allied Digital Services Limited (ADSL):企業の財務・戦略的SWOT分析
    Allied Digital Services Limited (ADSL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Cleveland BioLabs Inc (CBLI):企業の財務・戦略的SWOT分析
    Summary Cleveland BioLabs Inc (Cleveland) is a biopharmaceutical company that develops and commercializes drugs to treat cancer, orphan indications and protect healthy tissues from radiation and chemotherapy. The company’s product includes entolimod, a recombinant protein that acts as an agonist of …
  • O’Learys Trademark AB:企業の戦略・SWOT・財務分析
    O'Learys Trademark AB - Strategy, SWOT and Corporate Finance Report Summary O'Learys Trademark AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Sinopac Financial Holdings Company Limited
    Sinopac Financial Holdings Company Limited - Strategy, SWOT and Corporate Finance Report Summary Sinopac Financial Holdings Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Associated British Foods Plc:企業の戦略・SWOT・財務分析
    Associated British Foods Plc - Strategy, SWOT and Corporate Finance Report Summary Associated British Foods Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Eastman Chemical Co (EMN):企業の財務・戦略的SWOT分析
    Eastman Chemical Co (EMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆